M. Ouchi

Collaboration of signal transducer and activator of transcription 1 (STAT1) and BRCA1 in differential regulation of IFN-gamma target genes.

Mutsuko Ouchi, T. Ouchi, C. Horvath, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Virus-mediated oncolysis induces danger signal and stimulates cytotoxic T-lymphocyte activity via proteasome activator upregulation

T. Fujiwara, N. Tanaka, F. Uno, 2008, Oncogene.

Antiviral activity of cidofovir against telomerase-specific replication-selective oncolytic adenovirus, OBP-301 (Telomelysin)

T. Fujiwara, Y. Urata, M. Ouchi, 2009, Investigational New Drugs.

Overexpression of aurora kinase A in mouse mammary epithelium induces genetic instability preceding mammary tumor formation

C. Deng, T. Ouchi, M. Ouchi, 2006, Oncogene.

Preclinical evaluation of synergistic effect of telomerase-specific oncolytic virotherapy and gemcitabine for human lung cancer

T. Fujiwara, Dong Liu, Shinji Kuroda, 2009, Molecular Cancer Therapeutics.

In Vivo Biological Purging for Lymph Node Metastasis of Human Colorectal Cancer by Telomerase-Specific Oncolytic Virotherapy

S. Kyo, T. Fujiwara, H. Mizuguchi, 2010, Annals of surgery.

Efficient detection of human circulating tumor cells without significant production of false-positive cells by a novel conditionally replicating adenovirus

T. Fujiwara, H. Mizuguchi, F. Sakurai, 2016, Molecular therapy. Methods & clinical development.

Genetically engineered oncolytic adenovirus induces autophagic cell death through an E2F1‐microRNA‐7‐epidermal growth factor receptor axis

T. Fujiwara, Tsuyoshi Sasaki, F. Uno, 2012, International journal of cancer.

Genetically engineered oncolytic adenovirus induces autophagic cell death through an E2F1-microRNA-7-epidermal growth factor receptor axis

T. Fujiwara, Tsuyoshi Sasaki, F. Uno, 2013 .